mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis
Massimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, Pietro Annovazzi, Paola Cavalla, Valentina Torri Clerici, Paolo Ragonese, Viviana Nociti, Marta Radaelli, Alice Laroni, Fabio Buttari, Lorena Lorefice, Diana Ferraro, Alberto Gajofatto, Luca Prosperini, Roberta Fantozzi, Laura Boffa, Roberta Lanzillo, Marcello Moccia, Marinella Clerico, Giovanna De Luca, Valentina Tomassini, Massimiliano Calabrese, Angela Borrelli, Damiano Paolicelli, Giorgia Teresa Maniscalco, Paola Gazzola, Antonio Gallo, Claudio Solaro, Eleonora Cocco, Claudio Gasperini, Carla Tortorella
Abstract
N/A
Topics & Concepts
Multiple sclerosisCoronavirus disease 2019 (COVID-19)Term (time)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakImmunologyInternal medicineDiseaseInfectious disease (medical specialty)PhysicsOutbreakQuantum mechanicsRetinal and Optic ConditionsBacterial Infections and VaccinesLong-Term Effects of COVID-19